News

Sheila DeWitt, Epix’s former head of business development and current vice president of discovery and manufacturing, will lead the company’s business development efforts going forward. Dr DeWitt joined

Constructed using the Biomerix Biomaterial, Revive acts as a tissue scaffold facilitating rapid tissue ingrowth and can be utilized in a variety of soft tissue repair procedures, including

Under the terms of the contract, Skytron’s North American network of independent distributors will exclusively offer the patented Awarepoint real-time location system (RTLS) technology, marketed under the name,

As the CFO, Mr Komatz will plan and manage the company’s financial and accounting activities, and will communicate information about them to the board of directors and others.

With the consummation of the merger, Targanta has become a wholly owned subsidiary of The Medicines Company. Clive Meanwell, chairman and CEO of The Medicines Company, said: “This

Access gains the rights to MacroChem’s product portfolio which includes two clinical stage oncology products, 4-thio Ara-C (thiarabine), which is a next generation nucleoside analogue licensed from Southern

Cyclogenix has granted Wyeth exclusive rights to Cyclogenix’s novel drug discovery technology platform for use in generating therapeutic peptides, and Wyeth will fund research activities focused on using

Xylarex is a novel oral solution intended to be administered daily to reduce the number of ear infections children experience. The primary ingredient in Xylarex has also been

Fermiscan business update Commercialisation of the fermiscan breast cancer test in Australia is on plan Completion of a large scale (2,000 patient) clinical trial program in May 2008